Biomarkers of Osimertinib Response in Patients With Refractory, EGFR-T790M–Positive Non–Small Cell Lung Cancer and CNS Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Biomarkers of Osimertinib Response in Patients With Refractory, EGFR-T790M-Positive Non-Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study
Clin. Cancer Res 2020 Aug 17;[EPub Ahead of Print], L Xing, Y Pan, Y Shi, Y Shu, J Feng, W Li, L Cao, L Wang, W Gu, Y Song, P Xing, Y Liu, W Gao, J Cui, N Hu, R Li, H Bao, Y Shao, J YuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.